This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shanghai Yonsun Biotechnology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Wenfeng Xie
Introduction
Wenfeng Xie is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on lacosamide compositions. His research and inventions have the potential to enhance the effectiveness of pharmaceutical treatments.
Latest Patents
Wenfeng Xie holds a patent for a "Lacosamide pharmaceutical composition as well as preparation method and applications thereof." This patent describes a lacosamide pharmaceutical composition that allows for the simultaneous dissolution of lacosamide or its pharmaceutically acceptable salts. The composition demonstrates a dissolution rate of not more than 40% within 1 hour, 20-70% within 6 hours, and at least 65% within 24 hours. The formulation exhibits excellent slow-release performance, with the tablet size rapidly expanding during the in-vitro dissolution process. The expanded composition maintains good rigidity and elasticity, providing a remarkable retention effect in the stomach, with a cumulative release rate reaching 80% or above within 24 hours.
Career Highlights
Wenfeng Xie is associated with Shanghai Yonsun Biotechnology Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug formulations and enhancing patient outcomes.
Collaborations
Wenfeng collaborates with talented individuals such as Zhen Guo and Zuyou Chen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Wenfeng Xie's contributions to pharmaceutical innovations, particularly through his patent on lacosamide compositions, highlight his role as a significant inventor in the field. His work not only advances pharmaceutical science but also aims to improve therapeutic efficacy for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile